Your browser doesn't support javascript.
loading
A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide.
Yamaoka, Keiko; Nagashima, Shuichi; Okada, Nobukazu; Sawayama, Nagisa; Saito, Shinsuke; Takahashi, Manabu; Okada, Kenta; Endo, Kazuhiro; Koizumi, Masaru; Sasanuma, Hideki; Ebihara, Ken; Kasajima, Atsuko; Fukushima, Noriyoshi; Sata, Naohiro; Ishibashi, Shun.
Afiliación
  • Yamaoka K; Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan.
  • Nagashima S; Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan.
  • Okada N; Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan.
  • Sawayama N; Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan.
  • Saito S; Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan.
  • Takahashi M; Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan.
  • Okada K; Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan.
  • Endo K; Department of Surgery Jichi Medical University Shimotsuke Japan.
  • Koizumi M; Department of Surgery Jichi Medical University Shimotsuke Japan.
  • Sasanuma H; Department of Surgery Jichi Medical University Shimotsuke Japan.
  • Ebihara K; Division of Endocrinology and Metabolism Department of Medicine Jichi Medical University Shimotsuke Japan.
  • Kasajima A; Department of Pathology Tohoku University Graduate School of Medicine Sendai Japan.
  • Fukushima N; Present address: Department of Pathology Technical University Munich Munich Germany.
  • Sata N; Department of Pathology Jichi Medical University Shimotsuke Japan.
  • Ishibashi S; Department of Surgery Jichi Medical University Shimotsuke Japan.
Clin Case Rep ; 9(5): e04118, 2021 May.
Article en En | MEDLINE | ID: mdl-34026158
ABSTRACT
Long-acting somatostatin analogs, including lanreotide slow release (LAN-SR) and octreotide long-acting release (OCT-LAR), can improve hypoglycemia in insulinoma. LAN-SR may be more beneficial in some patients with insulinoma than OCT-LAR.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Case Rep Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Case Rep Año: 2021 Tipo del documento: Article